ArticleJACC. Heart failure2016
Patient and Facility Variation in Costs of VA Heart Failure Patients.
Article in JACC. Heart failure, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020).PharmacoEconomics · 2020Pooled it
- A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective.PharmacoEconomics · 2019Pooled it
- Costs and Healthcare Utilization of Heart Disease by COVID-19 Diagnosis and Race and Ethnicity.AJPM focus · 2025Article
- Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care.ESC heart failure · 2023Article
- Economic Issues in Heart Failure in the United States.Journal of cardiac failure · 2022Review
- Short and Mid-Term Economic Impact of Pulmonary Artery Catheter Use in Adult Cardiac Surgery: A Hospital and Integrated Health System Perspective.ClinicoEconomics and outcomes research : CEOR · 2021Article
- Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.JMIR mHealth and uHealth · 2020Article
- Home Telehealth Technologies for Heart Failure: An Examination of Adherence Among Veterans.Journal of gerontological nursing · 2020Article
- Association Between Spending and Survival of Chronic Heart Failure Across Veterans Affairs Medical Centers.JAMA network open · 2019Observational
- Quality and Value of Health Care in the Veterans Health Administration: A Qualitative Study.Journal of the American Heart Association · 2019Article
- Healthcare utilization and costs of cardiopulmonary complications following cardiac surgery in the United States.PloS one · 2019Article
- Patient and facility variation in costs of catheter ablation for atrial fibrillation.Journal of cardiovascular electrophysiology · 2018Article
- The Effect of Medicare Accountable Care Organizations on Early and Late Payments for Cardiovascular Disease Episodes.Circulation. Cardiovascular quality and outcomes · 2018Article
- The economics of heart failure care.Progress in cardiovascular diseasesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
Abstract
objectivesThis study sought to determine the variation in annual health care costs among patients with heart failure in the Veterans Affairs (VA) system.
backgroundHeart failure is associated with considerable use of health care resources, but little is known about patterns in patient characteristics related to higher costs.
methodsWe obtained VA utilization and cost records for all patients with a diagnosis of heart failure in fiscal year 2010. We compared total VA costs by patient demographic factors, comorbid conditions, and facility where they were treated in bivariate analyses. We regressed total costs on patient factors alone, VA facility alone, and all factors combined to determine the relative contribution of patient factors and facility to explaining cost differences.
resultsThere were 117,870 patients with heart failure, and their mean annual VA costs were $30,719 (SD 49,180) with more than one-half of their costs from inpatient care. Patients at younger ages, of Hispanic or black race/ethnicity, diagnosed with comorbid drug use disorders, or who died during the year had the highest costs (all p < 0.01). There was variation in costs by facility as mean adjusted costs ranged from approximately $15,000 to $48,000. In adjusted analyses, patient factors alone explained more of the variation in health care costs (R(2) = 0.116) compared with the facility where the patient was treated (R(2) = 0.018).
conclusionsA large variation in costs of heart failure patients was observed across facilities, although this was explained largely by patient factors. Improving the efficiency of VA resource utilization may require increased scrutiny of high-cost patients to determine if adequate value is being delivered to those patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.